Frown Lines

12 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
CU-20101 treatment for Moderate to Severe Glabellar Striae	Revance Therapeutics, Inc. (RVNC)

Unknown(1)

Drug	Company
prabotulinumtoxina	Evolus, Inc. (EOLS)

Phase 4(10)

Drug	Company
Botulinum Toxin A	Revance Therapeutics, Inc. (RVNC)
Botulinum Toxin A - Open Label	Revance Therapeutics, Inc. (RVNC)
Botulinum toxin A "BoNT/A-DP"	Revance Therapeutics, Inc. (RVNC)
Botulinum toxin A "Botox Cosmetics"	Revance Therapeutics, Inc. (RVNC)
daxxify	Revance Therapeutics, Inc. (RVNC)
onabotulinumtoxinA at a depth of 2mm	Revance Therapeutics, Inc. (RVNC)
onabotulinumtoxinA at a depth of 4mm	Revance Therapeutics, Inc. (RVNC)
onabotulinumtoxinA biosimilar	Revance Therapeutics, Inc. (RVNC)
OnabotulinumtoxinA X	Revance Therapeutics, Inc. (RVNC)
prabotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 12 drugs in development for Frown Lines across 2 companies.

There are 1 clinical trial targeting Frown Lines tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.